Archives

by in
Entry Author Date Location
East Coast Biotech Roundup: Sarepta, Aegerion, Syros, Aileron & More 10/31/14 Boston
Syros Raises $53M More To Push Gene-Control Drugs Into Human Trials 10/27/14 Boston
7 Takeaways From “What’s Hot in Boston Biotech” 04/22/14 Boston
What’s Hot in Boston Biotech: Here’s the Agenda for April 16 03/27/14 Boston
East Coast Biotech Roundup: Bristol-Myers, Syros, On-Q-ity, Ziopharm 04/12/13 Boston
Syros, a Whitehead and Dana-Farber Spinoff, Snags $30M For Cancer 04/11/13 Boston
Millennium, Banking on Velcade and More, Gears Up for Eagerly Anticipated Blood Cancer Meeting 12/02/10 Boston
Mike Huckman, Former CNBC Reporting Ace, Joins Stellar Lineup at Boston’s War on Cancer 10/14/10 Boston
Seattle Genetics, Millennium Nail 2nd Straight Trial With “Empowered Antibody” For Cancer 10/11/10 Seattle
Seattle Genetics, Millennium Generate “Dream” Data With Empowered Antibody Drug for Cancer 09/27/10 Seattle
What Is Boston Doing for the War on Cancer? Find Out at Xconomy Forum on October 20 08/25/10 Boston
Blood News: A Quick Rundown of Headlines From the American Society of Hematology 12/09/08 National
Millennium’s Velcade, As Time Wears On, Shows Durable Ability to Prolong Lives 12/08/08 Boston
Page 1 of 1